Please assess the completion status of the following clinical trial:

Trial Title: Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Participants between 18 and 55 years of age, in good general health, with pre-existing self-reported and clinically diagnosed tooth sensitivity are required for entry into the study.~* Participants will be required to have at least four teeth with facial/cervical erosion, abrasion and/or gingival recession which respond to qualifying evaporative (air) assessment at the Screening visit and have at least two teeth (incisors, canines or pre-molars) demonstrating signs of sensitivity, measured by qualifying tactile threshold (Yeaple ≤ 20 gram (g)) and evaporative (air) (Schiff Sensitivity Score ≥ 2) assessments at the Baseline visit.~Exclusion Criteria:~* Specific Dentition Exclusions for Test teeth~  1. Tooth with evidence of current or recent caries, or reported treatment of decay in 12 months of Screening.~ 2. Tooth with exposed dentin but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing etiologies other than erosion, abrasion or recession of exposed dentin.~ 3. Sensitive tooth not expected to respond to treatment with an over-the-counter dentifrice in the opinion of the investigator~* Use of a sensitivity dentifrice within 8 weeks of screening~* Individuals who require antibiotic prophylaxis for dental procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 5% calcium sodium phosphosilicate/ sodium monofluorophosphate (Type: EXPERIMENTAL): Dentifrice containing 5.0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate
- 0% calcium sodium phosphosilicate/sodium monofluorophosphate (Type: ACTIVE_COMPARATOR): Dentifrice containing 0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate
- Sodium monofluorophosphate (Type: ACTIVE_COMPARATOR): Dentifrice containing 1000 ppmF as sodium monofluorophosphate
- Sodium fluoride (Type: ACTIVE_COMPARATOR): Dentifrice containing 1100 ppmF as sodium fluoride

Based on this trial design, predict the completion outcome and termination type (if applicable).